Toxicologic findings in suicide: A 10-year retrospective review of Kentucky medical examiner cases

American Journal of Forensic Medicine and Pathology

Volumn 27, Issue 2, 2006, Pages 106-112

  Shields, Lisa B E ^a,d   Hunsaker, Donna M ^a,d,f   Hunsaker III, John C ^b,e   Ward, Michael K ^c  

^a Office of the Chief Medical Examiner   (United States)

^b Office of the Associate Chief Medical Examiner   (United States)

^c Medical Examiner's Office of Forensic Toxicology Laboratory   (United States)

^d University of Louisville School of Medicine   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f Urban Government Center   (United States)

Author keywords

Psychoactive substances; Suicide; Toxicology

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BROMPHENIRAMINE; CAFFEINE; CANNABINOID; CARBAMAZEPINE; CARISOPRODOL; CHLORPHENIRAMINE; COCAINE; DEXTROMETHORPHAN; DILTIAZEM; DIPHENHYDRAMINE; DOXYLAMINE; FLUCONAZOLE; GABAPENTIN; GUAIFENESIN; LIDOCAINE; MECLOZINE; MEPROBAMATE; NICOTINE; OPIATE; ORPHENADRINE; OXYBUTYNIN; PAPAVERINE; PARACETAMOL; PHENYLPROPANOLAMINE; PHENYTOIN; PROCAINAMIDE; UNINDEXED DRUG;

ADULT; ALCOHOL BLOOD LEVEL; AUTOPSY; BLOOD ANALYSIS; BLOOD SAMPLING; CARBON MONOXIDE INTOXICATION; CAUSE OF DEATH; CONTROLLED STUDY; DATA ANALYSIS; DRUG OVERDOSE; DRUG USE; FEMALE; GUNSHOT INJURY; HANGING; HEALTH CARE; HUMAN; MALE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SUICIDAL IDEATION; SUICIDE; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPHETAMINES; ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; CANNABINOIDS; CARBON MONOXIDE POISONING; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHILD; COCAINE; CYANIDES; DOPAMINE UPTAKE INHIBITORS; ETHANOL; ETHYLENE GLYCOL; FEMALE; FORENSIC MEDICINE; HUMANS; KENTUCKY; MALE; METHODS; MIDDLE AGED; NECK INJURIES; OVERDOSE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SUICIDE; WOUNDS, GUNSHOT;

EID: 33748483237     PISSN: 01957910     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.paf.0000220913.19508.99     Document Type: Review

References (50)

1. Centers for Disease Control and Prevention. Web-based Injury Statistics Query and Reporting System (WISQARS) [Online]. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (producer). Available at: http://www.cdc.gov/ncipc/wisqars. Accessed September 21, 2004.
2. Klerman GL. Clinical epidemiology of suicide. J Clin Psychiatry. 1987;48(12 suppl):33-38.
3. Mann JJ. Psychobiologic predictors of suicide. J Clin Psychiatry. 1987;48(12 suppl):39-43.
4. Maris RW. Suicide. Lancet. 2002;360:319-326.
5. Rosenberg ML, Davidson LE, Smith JC, et al. Operational criteria for the determination of suicide. J Forensic Sci. 1988;33:1445-1456.
6. Ho TP, Yip PSF, Chui CWF, et al. Suicide notes: what do they tell us? Acta Psychiatr Scand. 1998;98:467-473.
7. Litman RE, Curphey TJ, Shneidman ES, et al. Investigations of equivocal suicides. JAMA. 1963;184:924-929.
8. Norton LE, Garriott JC, DiMaio VJM. Drug detection at autopsy: a prospective study of 247 cases. J Forensic Sci. 1982;27:66-71.
9. Dhossche DM. Toxicology of suicide: touchstone for suicide prevention? Med Sci Monit. 2003;9:SR9-19.
10. Winek CL, Wahba WW, Winek CL Jr, et al. Drug and chemical blood-level data 2001. For Sci Int. 2001;122:107-123.
11. Dhossche DM, Rich CL, Ghani SO, et al. Patterns of psychoactive substance detection from routine toxicology of suicides in Mobile, Alabama, between 1990 and 1998. J Affect Disord. 2001;64:167-174.
12. Dhossche DM, Rich CL, Isacsson G. Psychoactive substances in suicides: comparison of toxicologic findings in two samples. Am J Forensic Med Pathol. 2001;22:239-243.
13. Rich CL, Isacsson G. Suicide and antidepressants in South Alabama: evidence for improved treatment of depression. J Affect Disord. 1997;45:135-142.
14. Mendelson WB, Rich CL. Sedatives and suicide: the San Diego study. Acta Psychiatr Scand. 1993;88:337-341.
15. Ohberg A, Vuori E, Ojanpera I, et al. Alcohol and drugs in suicides. Br J Psychiatry. 1996;169:75-80.
16. Hufford MR. Alcohol and suicidal behavior. Clin Psychol Rev. 2001;21:797-811.
17. Moscicki E. Epidemiology of suicide. In: Goldsmith S, ed. Risk Factors for Suicide. Washington, DC: National Academy Press; 2001:1-4.
18. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;56:617-626.
19. Stoudemire A, Wallack L, Hedenark N. Alcohol dependence and abuse. In: Amler RW, Dull HB, eds. Enclosing the Gap: The Burden of Unnecessary Illness. New York, NY: Oxford University Press; 1987:9-18.
20. Kaplan HI, Sadock BJ. Psychiatric emergencies. In: Kaplan HI, Sadock BJ, eds. Synopsis of Psychiatry. 8th ed. Baltimore, MD: Williams & Wilkins; 1998:864-872.
21. Duberstein PR, Conwell Y, Caine ED. Interpersonal stressors, substance abuse, and suicide. J Nerv Ment Dis. 1993;181:80-85.
22. Murphy GE, Armstrong JW, Hermele SL, et al. Suicide and alcoholism: interpersonal loss confirmed as a predictor. Arch Gen Psychiatry. 1979;45:593-594.
23. Murphy GE, Wetzel RD, Robins E, et al. Multiple risk factors predict suicide in alcoholism. Arch Gen Psychiatry. 1992;49:459-463.
24. Gruenewald PJ, Ponicki WF, Mitchell PR. Suicide rates and alcohol consumption in the United States, 1970-89. Addiction. 1995;90:1063-1075.
25. Rossow I. Alcohol and suicide: beyond the link at the individual level. Addiction. 1996;91:1413-1416.
26. Hayward L, Zubrick SR, Silburn S. Blood alcohol levels in suicide cases. J Epidemiol Community Health. 1992;46:256-260.
27. Welte JW, Abel EL, Wieczorek W. The role of alcohol in suicides in Erie County, NY, 1972-84. Public Health Rep. 1988;103:648-652.
28. Sikes RK. Alcohol and fatal injuries: Fulton County, Georgia, 1982. MMWR Morb Mortal Wkly Rep. 1983;32:573-576.
29. Scribante L, Blumenthal R, Saayman G, et al. A retrospective review of 1018 suicide cases from the capital city of South Africa for the period 1997-2000. Am J Forensic Med Pathol. 2004;25:52-55.
30. Gunnell D, Ashby D. Antidepressants and suicide: what is the balance of benefit and harm. BMJ. 2004;329:34-38.
31. Hampton T. Suicide caution stamped on antidepressants. JAMA. 2004;291:2060-2061.
32. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA. 2002;287:203-209.
33. Isacsson G. Suicide prevention: a medical breakthrough? Acta Psychiatr Scand. 2000;102:113-117.
34. Hall WD, Mant A, Mitchell PB, et al. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ. 2003;326:1008.
35. US Food and Drug Administration. US Food and Drug Administration psychopharmacological drugs advisory committee meeting, No. 34; September 20, 1991; Rockville, Md.
36. Müller-Oerlinghausen B, Berghöfer A. Antidepressants and suicidal risk. J Clin Psychiatry. 1999;60(suppl 2):S94-99.
37. Kapur S, Mieczkowski T, Mann JJ. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA. 1992;268:3441-3445.
38. Healy D. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychother Psychosom. 2003;72:71-79.
39. Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004;363:1341-1345.
40. Jureidini JN, Doecke CJ, Mansfield PR, et al. Efficacy and safety of antidepressants for children and adolescents. BMJ. 2004;328:879-883.
41. FDA Public Health Advisory. Worsening depression and suicidality in patients being treated with antidepressant medication. Available at: http://www.fda.gov/cder/drug/antidepressants/AntidepressantsPHA.htm. Accessed January 7, 2005.
42. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA. 2004;292:338-343.
43. Pomerantz JM. Controversy over suicide risk in children and adolescents taking antidepressants: lessons learned. Drug Benefit Trends. 2004;16:526-528.
44. Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J Clin Psychiatry. 1999;60(suppl 2):S57-62.
45. Healy D, Langmaak C, Savage M. Suicide in the course of the treatment of depression. J Psychopharmacol. 1999;13:94-99.
46. Isacsson G, Homgren P, Wasserman D, et al. Use of antidepressants among people committing suicide in Sweden. BMJ. 1994;308:506-509.
47. Marzuk PM, Tardiff K, Leon AC, et al. Use of prescription psychotropic drugs among suicide victims in New York City. Am J Psychiatry. 1995;152:1520-1522.
48. Isacsson G, Holmgren P, Druid H, et al. Psychotropics and suicide prevention: implications from toxicological screening of 5281 suicides in Sweden 1992-1994. Br J Psychiatry. 1999;174:259-265.
49. Brent DA, Perper JA, Allman CJ. Alcohol, firearms, and suicide among youth: temporal trends in Allegheny County, Pennsylvania, 1960 to 1983. JAMA. 1987;257:3369-3372.
50. Rich CL, Dhossche DM, Ghani S, et al. Suicide methods and presence of intoxicating abusable substances: some clinical and public health implications. Ann Clin Psychiatry. 1998;10:169-175.